Incidence and prevalence of dementia in Parkinson’s disease
نویسندگان
چکیده
use Abstract: This review addresses the literature surrounding Parkinson’s disease (PD) and mild cognitive impairment (MCI). It discusses the neuropsychological, pharmaceutical, and pathological overlap, the socioeconomic impact of PD and MCI, and the value of recognizing, understanding, and treating MCI in PD. It is concluded from this review that MCI in PD does exist and should be considered in clinical and research investigations. Due to the lack of accepted clinical criteria, an inclusive operating definition of MCI in PD is proposed. Research guidelines for studying the presence of MCI in PD and evaluating the efficacy of pharmaceutical interventions are also suggested.
منابع مشابه
تعیین ارتباط یافتههای VEP و SSEP باوجود دمانس در بیماران مبتلا به بیماری پارکینسون
Background & Aims: Parkinsonism occurs in all races. Its prevalence in the United States and Western Europe is 2.1 persons per 1,000 populations. Approximately one third of patients have cognitive problems that often doubles after 4 years in 80% of patients with dementia and Parkinson’s disease (PD) occurs in the final stages. The aim of this study was to determine the relationship between vis...
متن کاملCognitive profile and determinants of poor cognition in people without dementia in Parkinson’s disease
Background: The Montreal Cognitive Assessment (MoCA) has been recommended as a cognitive screening tool for clinical practice and research in Parkinson’s disease (PD), yet no normative data have been published for MoCA in PD without dementia. Methods: We undertook a pooled secondary analysis of data from two studies (one cross-sectional design and one clinical trial) conducted in the East ...
متن کاملCortical Lewy body disease.
C ortical Lewy body disease is a pathological observation rather than a distinct clinicopathological entity. Cortical Lewy bodies (CLB) are typically found in Parkinson’s disease and dementia with Lewy bodies (DLB), although they may also occur in other neurological disorders. Unlike their brain stem counterparts, CLB are less distinctive and are poorly visualised using conventional histochemic...
متن کاملRivastigmine in the Treatment of Alzheimer ’ s Disease and Parkinson ’ s Disease Dementia
Recent epidemiological evidence suggests a worldwide prevalence of 24.3 million cases of dementia, with one new case developing every seven seconds.1 Alzheimer’s disease (AD) remains the most common cause of dementia, responsible for 60–70% of cases in Europe.2 In addition, around 30% of patients with Parkinson’s disease (PD) are affected by dementia.3 In a 12-year population study of patients ...
متن کاملIndirect Estimation of Dementia Prevalence and Its Geographical Variation Using the Claim Data in Iran
Background and Objectives: Dementia is a chronic disease that imposes a huge financial and social burden on the health system. Knowledge of the prevalence of dementia is essential for healthcare planning and ensuring that there is an adequate service for people with the condition. Considering that the prevalence and geographical variation of dementia are not well known in Iran, the present stud...
متن کامل